Episode 194: Diabetic Retinopathy Trials and More with Dr. Judy Kim

Dr. Judy Kim joins to discuss how she applies recent diabetic retinopathy clinical trial results in her practice and applications of OCT angiography, among other topics.

Financial Disclosures:
Dr. Sridhar is a consultant for Alcon, Alimera, and Oxurion.
Dr. Kim is a consultant for Alimera Science, Allergan, Clearside, Eyepoint, Genentech, Graybug, Kodiak, Novartis, and Notal Vision and is on the drug, safety, and monitoring board for Cell Cure and Orbit.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.